Among Swedish cancer researchers: import immunological discoveries. Blocking antibodies favor tumor development
Osterberg, S.
Lakartidningen 67(39): 4424-4428
1970
ISSN/ISBN: 0023-7205 PMID: 5469221 Document Number: 19265
Document emailed within 1 workday
Related Documents
Gromkowski, S.H.; Heagy, W.; Sanchez-Madrid, F.; Springer, T.A.; Martz, E. 1983: Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and LYT-2,3. I. Increased susceptibility to blocking after papain treatment of target cells Journal of Immunology 130(6): 2546-2551Hirooka, Y.; Li, C.; Takagi, J.; Gotoh, M.; Habu, S.; Yasaka-Nomura, T.; Ishihara, R.; Nakasone, Y.; Nakamura, R.; Morikawa, R.; Otake, K.; Nogimori, T.; Ishizuki, Y. 2004: Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease International Journal of Clinical Pharmacology Research 24(4): 111-116
Tabár, L.; Fagerberg, G.; Day, N.E.; Duffy, S.W. 1992: The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumor characteristics Pathologie-Biologie 39(9): 846
Buist, D.; Tuzzio, L.; Greenlee, R.; Field, T.; Williams, A.; Weinmann, S.; Stout, N.; Kamineni, A.; Doubeni, C. 2012: PS1-33: Cancer Screening Guideline Development, Implementation and Dissemination: Connection Points for Researchers and Health Care Delivery Systems for Comparative Effectiveness Research Clinical Medicine and Research 10(3): 157-157
Yin, D.; Zhang, X.; Feng, Y. 1996: Effects of recombinant human tumor necrosis factor on the development of ascitic tumor and expression of c-erbB2 in the nude mouse models of ovarian cancer Zhonghua Fu Chan Ke Za Zhi 31(5): 291-292
Hagmayr, M. 2014: Artifact discoveries in Hartheim and their significance for memorial site development Historia Hospitalium 29: 222-236
Nakamura, R.; Saikawa, Y.; Hosokawa, S.; Fukuda, K.; Kumai, K.; Kubota, T.; Kitajima, M.; Kitagawa, Y. 2008: Development of 36 clones producing human monoclonal antibodies specific to cancer cells and their ability to inhibit cancer cell growth Anticancer Research 28(3a): 1651-1657
Friedell, G.H. 1971: Pathologic features of prognostic import in human cancer National Cancer Institute Monograph 34: 216-220
Rukhadze, E.Z. 1971: Lytic antibodies in antibacterial sera. 3. Competitive interaction of bacteriolytic antibodies of different immunological types Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 48(10): 37-42
Ghose, T.; Ramakrishnan, S.; Kulkarni, P.; Blair, A.H.; Vaughan, K.; Nolido, H.; Norvell, S.T.; Belitsky, P. 1981: Use of antibodies against tumor-associated antigens for cancer diagnosis and treatment Transplantation Proceedings 13(4): 1970-1972
Epenetos, A.A.; Shepherd, J.; Britton, K.E.; Hawkins, L.; Nimmon, C.C.; Taylor-Papadimitriou, J.; Durbin, H.; Malpas, J.S.; Mather, S.; Granowska, M. 1984: Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodies Cancer Detection and Prevention 7(1): 45-49
Pauwels, E.K.; Cleton, F.J.; Osanto, S. 1984: Scintigraphic studies in the detection of cancer using anti-tumor monoclonal antibodies Nederlands Tijdschrift Voor Geneeskunde 128(17): 805-809
Maianskiĭ, A.N.; Molchanova, I.V.; Iskhakova, S.K.; Ado, E.I.; Vershinina, V.I. 1982: Immunological reactivity to the products of normal microflora. IV. Antibodies to common species-specific pneumococcal antigens in the human spectrum of antibacterial antibodies Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 86-89
Souhami, R.L. 1994: Drug-DNA interactions: new discoveries and possibilities for cancer treatment Quarterly Journal of Medicine 87(4): 195-197
1997: Duke researchers link brain tumor drug resistance to mismatch repair deficiency Comprehensive Therapy 23(9): 622-623
2006: NIAID researchers make key discovery in development of TB drug candidate Journal of investigative medicine: the official publication of the American Federation for Clinical Research 54(2): 53-54
Katoh, H. 1982: Immunological regression of metastatic tumor cells after surgical excision of primary tumor Hokkaido Journal of Medical Science 57(1): 37-46
Björkman; Lundën, A.; Uggla, A. 1994: Prevalence of antibodies to Neospora caninum and Toxoplasma gondii in Swedish dogs Acta Veterinaria Scandinavica 35(4): 445-447
Sharkey, R.M.; Gold, D.V.; Aninipot, R.; Vagg, R.; Ballance, C.; Newman, E.S.; Ostella, F.; Hansen, H.J.; Goldenberg, D.M. 1990: Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens Cancer Research 50(3 Suppl): 828s-834s
Vila, M.; Duce, F.; Larrad, L.; de Gregorio, M.A.; Bello, S.; López, P. 1987: A study of IgG blocking antibodies in patients affected with respiratory allergy Allergologia et Immunopathologia 15(1): 43-48